Strong Showing at AngioDynamics Despite Diomed Baggage
The AP has a tendency to turn any earnings misstep into a headline. Such was the case with yesterday’s news that “AngioDynamics 1Q profit slips […]
news1
With FDA Clearance, Cepheid Expands Market for its MRSA Diagnostic
In July, Cepheid reported $42.1 million in second quarter revenues, a 55% jump from the $27.2 million reported in Q2 2007. Growth was been driven […]
[AdvaMed 2008] Video Roundup
Our in-house dynamo, Claudia Pinzon and the rest of the the talented team at OneMedTV, have been busy compiling a wealth of valuable video content […]
[Video Profile] Interview with Roger Kolanski, CEO of Critical Care Innovations
Critical Care Innovations (CCI), a biotechnology-driven device company, is developing minimally-invasive, site-specific and image-guided cancer management systems. By using ultrasound guidance and visualization technologies, along […]
GE Healthcare to Surreptitiously Monitor the Elderly through QuietCare Collaboration
GE Healthcare has entered into a distribution and technology collaboration with Living Independently Group (LIG). QuietCare, LIG’s principal product, is a “behavioral remote patient monitoring […]
GI Dynamics’ EndoBarrier Could Disrupt Gastric Bypass Surgery Market
According to the American Society for Bariatric Surgery, doctors perform 140,000 gastric bypass surgeries in the United States each year. The most common types are […]
[Video Profile] Arterial Remodeling Technologies
Arterial Remodeling Technologies (ART) is developing bioresorbable peripheral and coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty. ART’s bioresorbable […]
Biolase: Checking In on the Turnaround
In February, I reported that a turnaround at Biolase was underway. Improved relations with Henry Schein, a key distributor, were largely responsible for the upturn. […]
With MTX-100, BSD Medical Goes Head-to-Head with RF Ablation Technologies
BSD Medical, a developer of microwave systems used to treat cancer, has received FDA 510(k) clearance for its MicroThermX-100 Microwave Ablation System (MTX-100). MTX-100 is […]
What’s Next for NexMed?
After NexMed announced it would shelve its previously filed NDA for a toe nail fungus (TNF) treatment following disappointing Phase III clinical results, shares of the […]